| Item type |
学術雑誌論文 / Journal Article(1) |
| タイトル |
|
|
タイトル |
A Case of Persistent SARS-CoV-2 PCR Positive after Chemotherapy for B-cell Lymphoma |
| 言語 |
|
|
言語 |
eng |
| キーワード |
|
|
主題Scheme |
Other |
|
主題 |
B-cell lymphoma |
| キーワード |
|
|
主題Scheme |
Other |
|
主題 |
chemotherapy |
| キーワード |
|
|
主題Scheme |
Other |
|
主題 |
SARS-CoV-2 |
| キーワード |
|
|
主題Scheme |
Other |
|
主題 |
pneumonia |
| キーワード |
|
|
主題Scheme |
Other |
|
主題 |
antibody cocktail |
| キーワード |
|
|
主題Scheme |
Other |
|
主題 |
immunocompromised host |
| 資源タイプ |
|
|
資源タイプ識別子 |
http://purl.org/coar/resource_type/c_6501 |
|
資源タイプ |
journal article |
| 著者 |
Hirokawa, Hisanori
Hirata, Hirokuni
Kitajima, Ryo
Irokawa, Masahira
Ishiguro, Tomoyuki
Hasegawa, Tomoki
Sato, Junya
Ozaki, Atsutaka
Arima, Masafumi
Teramoto, Shinji
Haruki, Kosuke
Okamura, Takamitsu
Tamura, Hideto
Hashimoto, Koshi
Fukushima, Yasutsugu
|
| 著者所属 |
|
|
|
Department of Respiratory Medicine and Clinical Immunology, Dokkyo Medical University, Saitama Medical Center |
| 著者所属 |
|
|
|
Department of Respiratory Medicine and Clinical Immunology, Dokkyo Medical University, Saitama Medical Center |
| 著者所属 |
|
|
|
Department of Respiratory Medicine and Clinical Immunology, Dokkyo Medical University, Saitama Medical Center |
| 著者所属 |
|
|
|
Department of Respiratory Medicine and Clinical Immunology, Dokkyo Medical University, Saitama Medical Center |
| 著者所属 |
|
|
|
Department of Respiratory Medicine and Clinical Immunology, Dokkyo Medical University, Saitama Medical Center |
| 著者所属 |
|
|
|
Department of Respiratory Medicine and Clinical Immunology, Dokkyo Medical University, Saitama Medical Center |
| 著者所属 |
|
|
|
Department of Respiratory Medicine and Clinical Immunology, Dokkyo Medical University, Saitama Medical Center |
| 著者所属 |
|
|
|
Department of Respiratory Medicine and Clinical Immunology, Dokkyo Medical University, Saitama Medical Center |
| 著者所属 |
|
|
|
Department of Rheumatology, School of Medicine, Dokkyo Medical University, Tochigi, Japan |
| 著者所属 |
|
|
|
Department of Respiratory Medicine, Tokyo Medical University Hachioji Medical Center |
| 著者所属 |
|
|
|
Department of Laboratory Medicine, Dokkyo Medical University, Saitama Medical Center |
| 著者所属 |
|
|
|
Department of Diabetes, Endocrinology and Hematology, Dokkyo Medical University, Saitama Medical Center |
| 著者所属 |
|
|
|
Department of Diabetes, Endocrinology and Hematology, Dokkyo Medical University, Saitama Medical Center |
| 著者所属 |
|
|
|
Department of Diabetes, Endocrinology and Hematology, Dokkyo Medical University, Saitama Medical Center |
| 著者所属 |
|
|
|
Department of Respiratory Medicine and Clinical Immunology, Dokkyo Medical University, Saitama Medical Center |
| 書誌情報 |
Dokkyo Medical Journal
巻 1,
号 2,
p. 141-146,
発行日 2022-06
|
| 抄録 |
|
|
内容記述タイプ |
Abstract |
|
内容記述 |
The patient was a 68-year-old woman who was hospitalized for SARS-CoV-2 pneumonia while receiving chemotherapy for B-cell lymphoma. She experienced repeated episodes of pneumonia that temporarily went into remission with steroid and remdesivir and but then relapsed or worsened. However, no particular subjective symptoms or deterioration on imaging was observed by an antibody cocktail treatment after Day 119. SARS-CoV-2 IgM and IgG antibody levels were below the limit of detection on Day 180 but she tested positive for SARS-CoV-2 by PCR on Day 151. In the case of this patient who had persistent SARS-CoV-2 infection due to being immunocompromised, treatment temporarily stalled the worsening of symptoms. However, new treatments for such patients should be established soon. |
| 記事種別 |
|
|
|
Case Report |
| 出版者 |
|
|
出版者 |
Dokkyo Medical Society |
| ISSN |
|
|
収録物識別子タイプ |
ISSN |
|
収録物識別子 |
2436-5211 |
| DOI |
|
|
|
識別子タイプ |
DOI |
|
|
関連識別子 |
10.51040/dkmj.1.2_141 |
DKMJ-1-2-Hirokawa-Fulltext (704.4 kB)
.png)
